The global rise in dementia cases has researchers racing to uncover modifiable risk factors that might help prevent this devastating condition. A groundbreaking study from
A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications offer
Dementia, affecting millions worldwide, isn’t a single condition but rather an umbrella term encompassing various disorders that impair cognitive function, memory, and everyday capabilities. Each
